Abstract:Abstract Background To examine differences in the plasma levels of miRNA-21, − 214, −34a, and -200a in patients with persistent high-risk human papillomavirus (hr-HPV) infection or with cervical lesions of different grades. Methods Venous blood was collected from 232 individuals to measure the plasma expression levels of miRNA-21, − 214, −34a, and -200a. The subjects included normal controls and patients with persistent hr-HPV infection, CIN1, CIN2, CIN3, or cervical cancer (n = 42, 31, 19, 54, 71, and 15 patients, respectively). Cervical conization specimens were collected from all the women. To ensure the accuracy of histopathology, three consecutive tissue sections with an identical diagnosis were selected, and dissection samples were taken from them for miRNA detection. Eligible cases met the inclusion criteria based on sample observation using the middle slice of sandwich tissue sections from the pathological tissue in accordance with the diagnosis of CIN1, CIN2 and CIN3 in 8, 29, and 26 cases, respectively. The miRNA-21, − 214, −34a, and -200a expression levels in the paraffin-embedded tissue samples were determined. The percentage of patients with a CIN2+ diagnosis at 30–49 years old was significantly different from that of those diagnosed with CIN1. The incidence of CIN2+ patients exposed to passive smoking was significantly different from that of CIN1- patients. The percentage of CIN2+ patients with three pregnancies was significantly different from that of those with CIN1, and the percentage of CIN2+ subjects with ≥4 pregnancies was significantly different from that of CIN1- patients. The number of CIN2+ patients with two or more induced abortions was significantly different from that of patients with CIN1. The percentage of CIN2+ patients who underwent a caesarean section was significantly different from that of patients with CIN. The percentage of CIN2+ patients with first-degree relatives with cancer was significantly different from that of those with CIN1. Among CIN2+ patients, the percentage with a first sexual encounter at ≤20 years old was significantly different from that of those with CIN1. The percentage of CIN2+ patients with ≥2 sexual partners was significantly different from that of CIN1- patients. Results The plasma miRNA-214, −34a, and -200a expression levels were decreased in patients with more severe cervical lesions. Plasma miRNA levels in CIN1- patients were significantly different from those in CIN2+ patients. The kappa values for miRNA-21, − 214, −34a and -200a in tissue versus plasma were 0.7122, 0.9998, 0.8986 and 0.7458, respectively. The sensitivity of each biomarker for detecting CIN2 was calculated, and ROC curves of the four miRNA biomarkers were drawn. The AUC of the four plasma miRNAs was greater than 0.5, with the AUC of miRNA-21 being the largest at 0.703. The plasma miRNA expression levels exhibited at least one tie between CIN1 and CIN2. The AUCs for miRNA-21, −34a, −200a and − 214 were 0.613, 0.508, 0.615 and 0.505, respectively. Conclusions Changes in plasma miRNA-21, − 214, −34a and -200a levels were associated with cervical lesion severity. The plasma miRNA levels in CIN1- subjects were significantly different from those in CIN2+ subjects. This analysis may help in detection of high-grade cervical lesions.

Expression and significance of 4 miRNAs in cervical tissue of high-risk HPV infection

Progressive Mirna Expression Profiles in Cervical Carcinogenesis and Identification of Hpv-Related Target Genes for Mir-29

Reduced Mir-34a Expression In Normal Cervical Tissues And Cervical Lesions With High-Risk Human Papillomavirus Infection

Micrornas Are Biomarkers of Oncogenic Human Papillomavirus Infections

The roles and clinical significance of microRNAs in cervical cancer.

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Plasma Expression of Mirna-21, − 214, −34a, and -200A in Patients with Persistent HPV Infection and Cervical Lesions

Identification of Mir-23A As a Novel Microrna Normalizer for Relative Quantification in Human Uterine Cervical Tissues

Reduced Mir-100 Expression in Cervical Cancer and Precursors and Its Carcinogenic Effect Through Targeting PLK1 Protein.

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma

The Value of MicroRNA-375 Detection for Triaging Primary Human Papillomavirus Positive Women: A Cross-Sectional Study in a General Population.

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Expression Profile Of Circulating Micrornas As A Promising Fingerprint For Cervical Cancer Diagnosis And Monitoringy

Transcriptome Analysis Uncovers the Diagnostic Value of Mir-192-5p/hnf1a-as1/vil1 Panel in Cervical Adenocarcinoma

[Expression of Mir-Let-7e-3p in Cervical Intraepithelial Neoplasm and Cervix Carcinoma and Its Clinical Significance].

Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer

Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.

Significance of miR-141 and miR-340 in cervical squamous cell carcinoma

Profiling of Microrna-Mrna Reveals Roles of Micrornas in Cervical Cancer.

Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis

Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer